Changes in and impact of the death review process in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial

Reviews on Recent Clinical Trials

Volumn 10, Issue 3, 2015, Pages 206-211

  Miller, Anthony B ^a   Feld, Ronald ^b   Fontana, Robert ^c   Gohagan, John K ^d   Jatoi, Ismail ^e   Lawrence, Walter ^f   Miller, Amy ^g   Prorok, Philip C ^h   Rajput, Ashwani ⁱ   Sherman, Morris ^j   Welch, Gilbert ^k   Wright, Patrick ^l   Yurgalevitch, Susan ^g   Albertsen, Peter ^m  

^a UNIVERSITY OF TORONTO   (Canada)

^b PRINCESS MARGARET HOSPITAL   (Canada)

^c MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^f VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^g WESTAT   (United States)

^h NATIONAL CANCER INSTITUTE   (United States)

ⁱ UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^j TORONTO GENERAL HOSPITAL   (Canada)

^k DARTMOUTH INSTITUTE FOR HEALTH POLICY AND CLINICAL PRACTICE   (United States)

^l INFORMATION MANAGEMENT SERVICES INC   (United States)

^m UNIVERSITY OF CONNECTICUT   (United States)

more..

Author keywords

Colorectal cancer; Death certificates; Death review; Lung cancer; Ovarian cancer; Prostate cancer; Randomized screening trials

Indexed keywords

ALGORITHM; ARTICLE; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER MORTALITY; CANCER SCREENING; CAUSE OF DEATH; COLORECTAL CANCER; DEATH CERTIFICATE; HUMAN; LUNG CANCER; OVARY CANCER; PRIORITY JOURNAL; PROSTATE CANCER; COLORECTAL NEOPLASMS; EARLY CANCER DIAGNOSIS; FEMALE; LUNG NEOPLASMS; MALE; MORTALITY; MULTICENTER STUDY (TOPIC); NEOPLASMS; OVARIAN NEOPLASMS; PROCEDURES; PROSTATIC NEOPLASMS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SURVIVAL ANALYSIS; TRENDS;

ALGORITHMS; CAUSE OF DEATH; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MULTICENTER STUDIES AS TOPIC; NEOPLASMS; OVARIAN NEOPLASMS; PROSTATIC NEOPLASMS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SURVIVAL ANALYSIS;

EID: 84946084514     PISSN: 15748871     EISSN: 18761038     Source Type: Journal    
DOI: 10.2174/1574887110666150730120752     Document Type: Article

References (14)

1. Percy C, Stanek E III, Gloeckler L. Accuracy of cancer death certificates and its effect on cancer mortality statistics. Am J Public Health. 1981; 71(3): 242-50.
2. Messite J, Stellman SD. Accuracy of death certificate completion: the need for formalized physician training. JAMA 1996; 275(10): 794-6.
3. Black WC, Haggstrom DA, Welch HG. All-Cause Mortality in Randomized Trials of Cancer Screening. J Natl Cancer Inst 2002; 94:167-73.
4. Feuer EJ, Merrill RM, Hankey BF. Cancer surveillance series: Interpreting trends in prostate cancer-part II: Cause of death misclassification and the recent rise and fall in prostate cancer mortality. J Natl Cancer Inst 1999; 91: 1025-32.
5. Miller AB, Yurgalevitch S, Weissfeld JL. Death review process in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial. Control Clin Trials 2000; 21: 400S-6S.
6. Andriole GL, Crawford ED, Grubb III RL et al. Prostate cancer screening in the randomized prostate, lung, colorectal and ovarian cancer screening trial: Mortality results after 13 years of follow-up. J Natl Cancer Inst 2012; 104: 125-32.
7. Andriole GL, Grubb RL, Buys SS et al. Mortality results from a randomized prostate-cancer screening trial. New Eng J Med 2009; 360: 1310-9.
8. Doria-Rose VP, Marcus PM, Miller AB et al. Does the source of death information affect cancer screening efficacy results? A study of the use of mortality review versus death certificates in four randomized trials. Clin Trials 2010; 7: 69-77.
9. De Koning HJ, Blom J, Merkelbach JW et al. Determining the cause of death in randomized screening trial(s) for prostate cancer. BJU Int 2003; 92(Suppl 2): 71-8.
10. Makinen T, Karhunen P, Aro J, Lahtela J, Maattanen L, Auvinen A. Assessment of causes of death in a prostate cancer screening trial. Int J Can 2008;122: 413-7.
11. Otto SJ, van Leeuwen PJ, Hoekstra JW et al. Blinded and uniform causes of death verification in cancer screening: a major influence on the outcome of a prostate cancer screening trial? Eur J Cancer 2010; 46(17): 3061-7.
12. Godtman R, Holmberg E, Stranne J, Hugosson J. High accuracy of Swedish death certificates in men participating in screening for prostate cancer: a comparative study of official death certificates with a cause of death committee using a standardized algorithm. Scand J Urol Nephrol 2011; 45(4): 226-32.
13. Barry MJ, Andriole GL, Culkin DJ et al. Ascertaining cause of death among men in the prostate cancer intervention versus observation trial. Clin Trials 2013; 10(6): 907-14.
14. Marcus PM, Gareen IF, Miller AB et al. The National Lung Screening Trial's Endpoint Verification Process: Determining the cause of death. Contemp Clin Trials 2011; 32(6): 834-40.